HST Global, Inc. (HSTC)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
Dec 1, 2025, 4:00 PM EST
HST Global Market Cap
HST Global has a market cap or net worth of $133.04 million as of December 2, 2025. Its market cap has increased by 25,248.14% in one year.
Market Cap
133.04M
Enterprise Value
133.62M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
Market Cap Chart
Since May 12, 2008, HST Global's market cap has increased from 11.89M to 133.04M, an increase of 1,019.34%. That is a compound annual growth rate of 14.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 133.04M | 227.64% |
| Dec 30, 2024 | 40.61M | 1,173.50% |
| Dec 26, 2023 | 3.19M | 406.25% |
| Dec 30, 2022 | 629.83K | 9.09% |
| Dec 21, 2021 | 577.34K | 88.76% |
| Dec 31, 2020 | 305.86K | -40.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Elite Pharmaceuticals | 571.69M |
| Glass House Brands | 486.37M |
| American Oncology Network | 429.20M |
| CytoDyn | 414.34M |
| Northwest Biotherapeutics | 394.75M |
| Silence Therapeutics | 323.08M |
| Nika Pharmaceuticals | 259.96M |